Arrowhead Pharmaceuticals
ARWR
#2236
Rank
C$11.86 B
Marketcap
C$84.24
Share price
2.00%
Change (1 day)
52.81%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2026 (TTM): -C$0.23 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are C$0.66 Billion. In 2025 the company made an earning of C$0.48 Billion, an increase over its 2024 earnings that were of -C$0.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.23 Billion-147.07%
2025 C$0.48 B-157.5%
2024 -C$0.84 Billion112.45%
2023 -C$0.4 Billion87.79%
2022 -C$0.22 Billion-20.1%
2021 -C$0.27 Billion67.59%
2020 -C$0.16 Billion-347.53%
2019 C$63.5 M-245.59%
2018 -C$43.63 Million-13.17%
2017 -C$50.24 Million-52.28%
2016 -C$0.11 Billion-16.57%
2015 -C$0.13 Billion30.32%
2014 -C$96.84 Million171.62%
2013 -C$35.66 Million16.56%
2012 -C$30.59 Million107.53%
2011 -C$14.74 Million
2008 -C$51.92 Million-8.07%
2007 -C$56.47 Million70.37%
2006 -C$33.15 Million122.51%
2005 -C$14.9 Million147.41%
2004 -C$6.03 Million2002.28%
2003 -C$0.29 Million-85.61%
2002 -C$2 Million1371.97%
2001 -C$0.14 Million-13.45%
2000 -C$0.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.66 B-16,534.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-C$4.27 Billion 1,809.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.34 B-253.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$1.57 B-805.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-C$0.12 Billion-48.39%๐Ÿ‡บ๐Ÿ‡ธ USA